Novel Therapies in Hepatitis C Virus, An Issue of Clinics in Liver Disease, 1st Edition
Author :
Paul J. Pockros
Date of Publication: 08/2009
The Guest Editor presents state-of-the-art articles devoted to therapies for treatment of HCV. The novel therapies addressed in this issue include interferons, viral kinetics and anti-viral resistence, anti-fibrotics, immunotherapeutics, hepatoprotec ...view more
The Guest Editor presents state-of-the-art articles devoted to therapies for treatment of HCV. The novel therapies addressed in this issue include interferons, viral kinetics and anti-viral resistence, anti-fibrotics, immunotherapeutics, hepatoprotectants and caspace inhibitors, and cyclosporine analogues, to name a few.
The Guest Editor presents state-of-the-art articles devoted to therapies for treatment of HCV. The novel therapies addressed in this issue include interferons, viral kinetics and anti-viral resistence, anti-fibrotics, immunotherapeutics, hepatoprotectants and caspace inhibitors, and cyclosporine analogues, to name a few.
Author Information
By Paul J. Pockros, MD, Scripps Research Institute, La Jolla, CA
https://www.eu.elsevierhealth.com/novel-therapies-in-hepatitis-c-virus-an-issue-of-clinics-in-liver-disease-9781437712360.html72994Novel Therapies in Hepatitis C Virus, An Issue of Clinics in Liver Diseasehttps://www.eu.elsevierhealth.com/media/catalog/product/9/7/9781437712360_2.jpg77.8981.99EURInStock/Medicine and Surgery/Gastroenterology & Hepatology/Books/Clinics Review Articles9857525503956128371745498285145120The Guest Editor presents state-of-the-art articles devoted to therapies for treatment of HCV. The novel therapies addressed in this issue include interferons, viral kinetics and anti-viral resistence, anti-fibrotics, immunotherapeutics, hepatoprotectants and caspace inhibitors, and cyclosporine analogues, to name a few. The Guest Editor presents state-of-the-art articles devoted to therapies for treatment of HCV. The novel therapies addressed in this issue include interferons, viral kinetics and anti-viral resistence, anti-fibrotics, immunotherapeutics, hepatoprotectants and caspace inhibitors, and cyclosporine analogues, to name a few.00add-to-cart97814377123602011 and earlierProfessionalBy Paul J. Pockros, MD20091Book152w x 229h (6.00" x 9.00")Saunders028 Aug 2009PRINT ON DEMAND - DELIVERY CAN TAKE UP TO 10 DAYSBy <STRONG>Paul J. Pockros</STRONG>, MD, Scripps Research Institute, La Jolla, CAClinicsThe Clinics: Internal MedicineNoNoNoNoPlease SelectPlease SelectPlease Select
